Billy Clowney

890 total citations
7 papers, 233 citations indexed

About

Billy Clowney is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Billy Clowney has authored 7 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Billy Clowney's work include Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (6 papers) and Cancer Treatment and Pharmacology (2 papers). Billy Clowney is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (6 papers) and Cancer Treatment and Pharmacology (2 papers). Billy Clowney collaborates with scholars based in United States and United Kingdom. Billy Clowney's co-authors include Robert M. Rifkin, Veena Charu, Rubén Niesvizky, Ian W. Flinn, Nashat Gabrail, Yousuf Gaffar, James A. Reeves, James Essell, Dixie‐Lee Esseltine and Liviu Niculescu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Oncologist.

In The Last Decade

Billy Clowney

7 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Billy Clowney United States 6 220 173 144 27 11 7 233
Claudia Polloni Italy 8 167 0.8× 136 0.8× 106 0.7× 22 0.8× 16 189
Yousuf Gaffar United States 6 202 0.9× 188 1.1× 149 1.0× 23 0.9× 9 218
Lisa Barbarotta United States 7 46 0.2× 73 0.4× 41 0.3× 22 0.8× 11 1.0× 12 143
Nina Shah United States 4 97 0.4× 66 0.4× 65 0.5× 10 0.4× 5 124
Carol Delaney United States 2 122 0.6× 110 0.6× 62 0.4× 8 0.3× 4 130
Ashraf Elghandour Egypt 5 119 0.5× 133 0.8× 71 0.5× 6 0.2× 11 174
Lisa Nardelli United States 8 183 0.8× 160 0.9× 114 0.8× 23 0.9× 12 230
Kristen Detweiler Short United States 3 149 0.7× 118 0.7× 81 0.6× 24 0.9× 5 151
Diamond Zuchlinski United States 4 99 0.5× 74 0.4× 44 0.3× 17 0.6× 5 103
María José Sayas Spain 4 155 0.7× 147 0.8× 22 0.2× 23 0.9× 10 0.9× 8 202

Countries citing papers authored by Billy Clowney

Since Specialization
Citations

This map shows the geographic impact of Billy Clowney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Billy Clowney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Billy Clowney more than expected).

Fields of papers citing papers by Billy Clowney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Billy Clowney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Billy Clowney. The network helps show where Billy Clowney may publish in the future.

Co-authorship network of co-authors of Billy Clowney

This figure shows the co-authorship network connecting the top 25 collaborators of Billy Clowney. A scholar is included among the top collaborators of Billy Clowney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Billy Clowney. Billy Clowney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Niesvizky, Rubén, Ian W. Flinn, Robert M. Rifkin, et al.. (2015). Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens. Journal of Clinical Oncology. 33(33). 3921–3929. 121 indexed citations
2.
3.
4.
Niesvizky, Rubén, Ian W. Flinn, Robert M. Rifkin, et al.. (2010). Patient-Reported Quality of Life In Elderly, Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib-Based Regimens: Results From the Phase 3b UPFRONT Study. Blood. 116(21). 3026–3026. 3 indexed citations
5.
6.
7.
Boccia, Ralph V., Imtiaz A. Malik, Stephen P. Kahanic, et al.. (2006). Darbepoetin Alfa Administered Every Three Weeks Is Effective for the Treatment of Chemotherapy-Induced Anemia. The Oncologist. 11(4). 409–417. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Polloni Breakdown of academic impact, for papers by Yousuf Gaffar Breakdown of academic impact, for papers by Lisa Barbarotta Breakdown of academic impact, for papers by Nina Shah Breakdown of academic impact, for papers by Carol Delaney Breakdown of academic impact, for papers by Ashraf Elghandour Breakdown of academic impact, for papers by Lisa Nardelli Breakdown of academic impact, for papers by Kristen Detweiler Short Breakdown of academic impact, for papers by Diamond Zuchlinski Breakdown of academic impact, for papers by María José Sayas
Rankless by CCL
2026